FE 999315

· Ferring Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FE 999315, covering 2020-06-18 to 2020-06-18. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative Colitis [Phase 3]

See pricing